✦ LIBER ✦

EORTC 10941; Final results of a phase II study of liarozole fumarate in patients with metastatic breast cancer

✍ Scribed by J. Klijn; A. Hamilton; L. Beex; L. Mauriac; R. Paridaens; J.A. Roy; A. Awada; A. Van Vreckem; P. Palmer; M. Piccart

Book ID: 117666189
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 140 KB
Volume: 34
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(98)80068-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EORTC 10941: A phase II study of liarozo

EORTC 10941: A phase II study of liarozole in postmenopausal patients with ‘Chemotherapy-Resistant’ or ‘Potentially Hormone Sensitive’ metastatic breast cancer

✍ A. Hamilton; J.-A. Roy; L. Beex; M. Piccart; L. Mauriac; R. Coleman; R. Paridaen 📂 Article 📅 2000 🏛 Springer US 🌐 English ⚖ 51 KB

PP-7-1 phase II study of liarozole in ad

PP-7-1 phase II study of liarozole in advanced breast cancer patients

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 150 KB

Carboplatin activity in untreated metast

Carboplatin activity in untreated metastatic breast cancer patients — results of a phase II study

✍ K. Kolarić; D. Vukas 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 388 KB

Phase II study of ionidamine in patients

Phase II study of ionidamine in patients with metastatic breast cancer

✍ H. Ian Robins; Donna S. Neuberg; Al B. Benson; Kishan J. Pandya; Douglass C. Tor 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 193 KB

The Eastern Cooperative Oncology Group conducted a phase II study of lonidamine in patients with metastatic breast cancer. The drug was given orally to a maximum daily dose of 340 mg/m 2. Forty-two patients were entered on study. One partial response was observed; there were no life-threatening toxi

Phase II study in patients (PTS) with me

Phase II study in patients (PTS) with metastatic breast cancer (MBC)

✍ Giocomi, N.; Pascual, M.; García, J.; Stagnaro, A.; Chirino, M.; Algamiz, C.; Es 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 173 KB

664 - Phase II study of gemcltablne in p

664 - Phase II study of gemcltablne in patients with metastatic breast cancer

✍ M. Blackstein; C.L. Vogel; R. Ambinder; J. Cowan; P. Pearce; J. Iglesias 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 266 KB